Insider Sell: Exec Chairman Wayne Deveydt Sells 168,130 Shares of Surgery Partners Inc (SGRY)
Wayne Deveydt, the Executive Chairman of the Board of Surgery Partners Inc (NASDAQ:SGRY), has executed a significant stock sale according to a recent SEC filing. On December 19, 2023, the insider sold 168,130 shares of the company.
Surgery Partners Inc is a healthcare services company that operates surgical facilities across the United States. The company's integrated healthcare delivery model provides a range of services, including surgical facility operation, ancillary services, and optical services. Surgery Partners Inc is committed to delivering high-quality surgical care and enhancing patient and physician satisfaction.
Over the past year, Wayne Deveydt has sold a total of 168,130 shares and has not made any purchases of the company's stock. This latest transaction continues the trend observed over the past year, where there have been no insider buys and 26 insider sells for Surgery Partners Inc.
On the date of the insider's recent sale, shares of Surgery Partners Inc were trading at $33.44, resulting in a market capitalization of $4.079 billion.
The stock's valuation, as indicated by the price-to-GF-Value ratio, stands at 1.23, suggesting that Surgery Partners Inc is modestly overvalued when compared to its GF Value of $27.28. The GF Value is a proprietary intrinsic value estimate from GuruFocus, which factors in historical trading multiples, a GuruFocus adjustment factor based on the company's historical returns and growth, and future business performance estimates from Morningstar analysts.
The insider trend image above reflects the recent insider selling activity for Surgery Partners Inc.
The GF Value image provides a visual representation of the stock's current valuation in relation to its intrinsic value as estimated by GuruFocus.
For more detailed information and analysis on insider transactions and the company's financials, interested individuals can refer to the full SEC filing.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
